SCHEMBL22064467

SCHEMBL22064467

CNC1CCN(C(=O)OC)C1COC1CCC(c2ccccc2)CC1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HCRTR2 O43614 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22064324 0.93 HCRTR2 (0.71) HCRTR2
SCHEMBL24411300 0.89 HCRTR2 (0.73) HCRTR2
SCHEMBL22346123 0.89 HCRTR2 (0.73) HCRTR2
SCHEMBL24411301 0.89 HCRTR2 (0.73) HCRTR2
SCHEMBL22762081 0.89 HCRTR2 (0.89) HCRTR2
SCHEMBL24411373 0.89 HCRTR2 (0.89) HCRTR2
SCHEMBL24411236 0.89 HCRTR2 (0.89) HCRTR2
SCHEMBL22023352 0.89 HCRTR2 (0.89) HCRTR2
SCHEMBL22023303 0.89 HCRTR2 (0.89) HCRTR2
SCHEMBL22346539 0.89 HCRTR2 (0.89) HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663281-B1 HETEROCYCLIC COMPOUND AND APPLICATION THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2022-12-28 — — EP disclosed
EP-3663281-A1 HETEROCYCLIC COMPOUND AND APPLICATION THEREOF Takeda Pharmaceutical Company Limited (JP) 2020-06-10 — — EP disclosed
Send feedback